Abstract:
The invention discloses an application management and execution system and a method thereof. The application management and execution system comprises a virtual machine monitor for managing at least one virtual machine; the at least one virtual machine for processing at least one application, and storing, separately and respectively, application data used by each application and platform data required by the virtual machine for processing the application in one or more storage disk (persistent storage), and reading the application data and the platform data from the one or more storage devices respectively. The at least one application executing on the virtual machine may share the platform data in the one or more storage devices. When the virtual machine executes the at least one application, it may modify the application data in the storage devices.
Abstract:
The compounds of the present invention are represented by the following aryl- and heteroaryl-substituted tetrahydrobenzazepine and dihydrobenzazapine derivatives having formulae I(A-E) and formula (II): where the carbon atom designated * is in the R or S configuration, and the substituents X and R1-R9 are as defined herein.
Abstract:
The present invention provides stable glycosaminoglycan (GSG) structures and methods of use of such GAG structures. These structures comprise a core of free GAG, a coating of crosslinked GAG surrounding the core, and a layer of a positively charged moiety surrounding the crosslinked GAG layer. These GAG structures provide improved stability, both in in vivo and external use. Furthermore, resurfacing of the structures provides improved cell adhesion and thus improved delivery of the GAG into living cells and tissues.